| ISIVX | VTSMX | ISIVX / VTSMX | |
| Total Expense Ratio | 0.80 | 0.14 | 571% |
| Annual Report Gross Expense Ratio | 0.80 | 0.14 | 571% |
| Fund Existence | 17 years | 34 years | - |
| Gain YTD | 4.152 | 16.390 | 25% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 3000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.68B | 2.06T | 0% |
| Annual Yield % from dividends | 0.69 | 1.02 | 68% |
| Returns for 1 year | 0.72 | 11.53 | 6% |
| Returns for 3 years | 29.24 | 69.00 | 42% |
| Returns for 5 years | 14.32 | 76.72 | 19% |
| Returns for 10 years | 65.99 | 228.23 | 29% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MSERX | 10.58 | 0.09 | +0.86% |
| MassMutual Small Cap Growth Eq R4 | |||
| OEGCX | 20.72 | 0.17 | +0.83% |
| Invesco Discovery Mid Cap Growth C | |||
| BGEIX | 29.14 | 0.10 | +0.34% |
| American Century Global Gold Inv | |||
| TASZX | 21.83 | -0.06 | -0.27% |
| Third Avenue Small Cap Value Z | |||
| SBHIX | 26.47 | -0.13 | -0.49% |
| Saratoga Health & Biotechnology I | |||